Industry News
-
Mass General Brigham-Led Consortium Wins ARPA-H Award to Advance On-Demand Manufacturing of Genetic Medicines
Sep 08 2026 -
Bristol Myers Reports Phase 2 Success for GPRC5D-Directed CAR-T in Relapsed/Refractory Multiple Myeloma
Sep 08 2026 -
Early Phase 1 Results for BAFF-R-Targeted CAR T Show Durable Complete Responses in R/R B-Cell Lymphoma, Including After Prior CD19 CAR-T Failure
Sep 08 2026 -
BrainChild Bio Raises $116M Series A to Advance CAR-T Cell Therapies for Pediatric Brain Cancers
Sep 08 2026 -
Base-Editing Study Reports Durable Clinical Benefits in Sickle Cell Disease and Beta-Thalassemia Across Diverse Genetic Backgrounds
Sep 07 2026 -
Rznomics Reports Major Advance in High-Efficiency Circular RNA Production in Nucleic Acids Research
Sep 07 2026 -
Ionis Wins First FDA Approval of a Disease-Modifying Therapy for Alexander Disease
Sep 04 2026 -
Typewriter Therapeutics Raises $56M Series A to Advance Non-Viral In Vivo Gene Therapy Platform
Sep 03 2026 -
uniQure Submits FDA Application for AAV Gene Therapy AMT-130, Seeking First Approved Treatment for Huntington’s Disease
Sep 02 2026